Nader Fotouhi Selected Research

Nader Fotouhi Research Topics

Disease

11	Tuberculosis (Tuberculoses) 02/2024 - 01/2019
6	Neoplasms (Cancer) 03/2024 - 02/2004
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2023 - 01/2021
4	Infections 10/2022 - 01/2019
2	Extensively Drug-Resistant Tuberculosis 02/2024 - 11/2021
1	Persistent Infection 10/2023
1	Granuloma 01/2023
1	Bacteremia 10/2022
1	Wound Infection (Wound Infections) 10/2022
1	Staphylococcal Infections 10/2022
1	Inflammation (Inflammations) 06/2010
1	Pneumonia (Pneumonitis) 06/2010
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 06/2010
1	Asthma (Bronchial Asthma) 06/2010
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2010
1	Acute Lung Injury 06/2010

Drug/Important Bio-Agent (IBA)

6	Linezolid (Zyvox)FDA Link 02/2024 - 01/2019
6	pretomanidIBA 02/2024 - 01/2019
6	bedaquiline (R207910)IBA 02/2024 - 01/2019
3	DiarylquinolinesIBA 01/2023 - 01/2021
2	Heme Oxygenase-1IBA 12/2023 - 11/2023
2	MetalloporphyrinsIBA 12/2023 - 11/2023
2	tin mesoporphyrinIBA 12/2023 - 11/2023
2	Antitubercular AgentsIBA 10/2023 - 01/2022
2	TBAJ-876IBA 01/2023 - 11/2021
2	Oxazolidinones (2 Oxazolidone)IBA 01/2023 - 10/2022
2	Moxifloxacin (Avelox)FDA Link 01/2021 - 01/2019
2	Pyrazinamide FDA LinkGeneric 01/2021 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2010 - 03/2009
1	raltitrexed (D 1694)IBA 03/2024
1	Thymidylate SynthaseIBA 03/2024
1	phosphopantetheinyl transferaseIBA 03/2024
1	contezolidIBA 12/2023
1	CytochromesIBA 10/2023
1	duroquinol oxidaseIBA 10/2023
1	Oxidoreductases (Dehydrogenase)IBA 10/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2022
1	PlacebosIBA 10/2022
1	Lysine-tRNA LigaseIBA 10/2022
1	Drug CombinationsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	ATSP-7041IBA 09/2013
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 06/2010
1	4- (3- (6- (3- benzo(1,3)dioxol- 5- yl- 5- thiophen- 3- ylphenoxy)hexyl)- 2- (2- carboxyethyl)phenoxy)butyric acidIBA 06/2010
1	Leukotriene B4IBA 06/2010
1	Phosphotransferases (Kinase)IBA 01/2010
1	2- (4- (4- (2,3- dihydroxy- propoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- N- (2- fluoro- 4- iodo- phenyl)- 3- phenylbutyramideIBA 01/2010
1	MAP Kinase Kinase 1IBA 03/2009
1	(2S,3S)- 2- ((R)- 4- (4- (2- hydroxyethoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- 3- phenyl- N- (4- propionylthiazol- 2- yl)butyramideIBA 03/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2009
1	AgarIBA 02/2008
1	Small Interfering RNA (siRNA)IBA 02/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2008
1	Antineoplastic Agents (Antineoplastics)IBA 02/2008

Therapy/Procedure

4	Therapeutics 01/2021 - 02/2004
2	Duration of Therapy 01/2022 - 01/2019
1	Secondary Prevention 01/2023